ASP Isotopes Inc. Common Stock
NASDAQ:ASPIChemicals
+$0.32 today
- Market cap
- $191.68M
- Beta
- 3.44
- P/E (TTM)
- -4.9
- EPS (TTM)
- -$1.43
Volume 7.05M
Average 5.68M
ASPI Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
ASP Isotopes Inc. Common StockNASDAQ: ASPI
Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026
Stock-based compensation growth accelerates
Q1 FY2026 stock-based compensation of $4.41M rose 133.5% year over year, ahead of the +112.3% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 15.5% from the prior quarter. Over 3 fiscal years it compounded at +100.1% a year.
Context
- Stock-based compensation amounted to 67.2% of revenue in FY2025, down 139.4 pp from a year earlier.
- Stock-based compensation increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +133.5% holds above the trailing-twelve-month pace of +112.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 16.02M USD
- Year-over-year change
- +87.2%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 16.02M | +87.2% |
| FY2024 | 2024-12-31 | 8.56M | -2.1% |
| FY2023 | 2023-12-31 | 8.74M | +337.3% |
| FY2022 | 2022-12-31 | 2M | — |
| FY2021 | 2021-12-31 | 0 | — |
Stock-Based Compensation vs competitors
How ASPI compares with its peers on the latest reported figures
- Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +112.3% is the 3rd highest of 10, against a peer median of +2.6%.
- Stock-based compensation amounts to 68.9% of revenue for ASPI, versus a peer median of 0.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $21M USD | +5.0% | -90.8% | 0.7% | |
| LTM Mar 2026 | $18.55M USD | +112.3% | +100.1% | 68.9% | |
| LTM Mar 2026 | $8.31M USD | +85.1% | -46.2% | 0.4% | |
| LTM Mar 2026 | $8M USD | +2.6% | -13.4% | 0.6% | |
| LTM Mar 2026 | $4.89M USD | -65.1% | — | 0.3% | |
| LTM Mar 2026 | $2.98M USD | +775.6% | +386.6% | 7.6% | |
| LTM Mar 2026 | $1.81M USD | +269.2% | — | 1.4% | |
| LTM Apr 2026 | $1.27M USD | -75.1% | +25.1% | 0.3% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | R$0 BRL | -100.0% | — | 0.0% | |
| Peer median (excluding ASPI) | — | +2.6% | -13.4% | 0.3% | |
Competitors are the stored peer set for ASPI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (2.61M) | (4.95M) | (16.29M) | (32.42M) | (159.84M) |
| Depreciation & Amortization | 19.38K | 72.57K | 37.43K | 471.42B | 1.91M |
| Deferred Income Tax | 0 | (72.57K) | 16.66K | (143.28K) | (45K) |
| Stock-Based Compensation | 0 | 2M | 8.74M | 8.56M | 16.02M |
| Change in Working Capital | (238.21K) | 33.89K | 1.16M | (2.62M) | (3.63M) |
| Accounts Receivables | 0 | 0 | 237.95K | (505.95K) | (454K) |
| Inventory | 0 | 0 | 0 | (67.64K) | (315K) |
| Accounts Payables | 59.68K | 570.6K | (224.6K) | (877.47K) | 782K |
| Other Working Capital | (297.89K) | (536.71K) | 1.15M | (1.17M) | (3.64M) |
| Other Non-Cash Items | 2.23M | (27.96K) | 924.12K | (471.41B) | 107.8M |
| Operating Cash Flow | (577.69K) | (2.94M) | (5.41M) | (16.7M) | (37.78M) |
| Capital Expenditures | (2.99M) | (4.47M) | (2.33M) | (11.37M) | (9.65M) |
| Acquisitions (Net) | 0 | 0 | (121.85K) | 0 | 25.37M |
| Purchases of Investments | 0 | 0 | 0 | 0 | (75.74M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (29.97M) |
| Investing Cash Flow | (2.99M) | (4.47M) | (2.45M) | (11.37M) | (90M) |
| Debt Repayment | 46.9K | (13.05K) | (180.53K) | 25.72M | 44.11M |
| Common Stock Issued | 6.45M | 8.12M | 14.13M | 53.09M | 307.09M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | (2.78T) | 0 |
| Other Financing Activities | 0 | (1.47M) | (563.47K) | 2.78T | (402K) |
| Financing Cash Flow | 6.5M | 6.64M | 13.39M | 82.53M | 350.8M |
| Effect of Forex Changes | 18.72K | 207.42K | (867) | (484.01K) | 646.95K |
| Net Change in Cash | 2.93M | (564.58K) | 5.52M | 53.98M | 223.67M |
| Free Cash Flow | (3.57M) | (7.41M) | (7.74M) | (28.07M) | (47.43M) |
ASP Isotopes Inc. Common Stock
NASDAQ:ASPI
Intrinsic Alpha fair value
Locked
Current Price
$1.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.